Podcast Episodes
Back to SearchSequencing Targeted Therapies in the Management of Patients With CLL
Episode 603
Drs. Coombs and Danilov explore how to optimally sequence covalent BTK inhibitors, non‑covalent BTK inhibitors (such as pirtobrutinib), and venetocla…
8 months, 1 week ago
Sequencing Targeted Therapies in the Management of Patients With CLL
Episode 603
Drs. Coombs and Danilov explore how to optimally sequence covalent BTK inhibitors, non‑covalent BTK inhibitors (such as pirtobrutinib), and venetocla…
8 months, 1 week ago
What does current evidence show about acetaminophen use in pregnancy?
Episode 602
A large Lancet meta-analysis found no clinically meaningful association between prenatal acetaminophen exposure and autism, ADHD, or intellectual dis…
8 months, 2 weeks ago
Should clinicians routinely ask patients about firearm access?
Episode 601
Firearm ownership has surged in the U.S., yet safety discussions remain uncommon in clinical care. An NEJM article supports routine, nonpolitical fir…
8 months, 3 weeks ago
Are missed 2-month vaccines the strongest warning sign for future MMR refusal?
Episode 600
A large U.S. cohort study found that children who were late for routine 2- or 4-month immunizations were six to seven times more likely to miss MMR v…
8 months, 3 weeks ago
Do GLP-1 weight-loss drugs also reduce asthma attacks in teens?
Episode 599
New real-world data suggest that GLP-1 receptor agonists used for adolescent obesity are associated with roughly half the rate of asthma exacerbation…
8 months, 3 weeks ago
What happens to factor Xa reversal strategies now that andexanet is leaving the U.S.?
Episode 598
The FDA has issued a major safety alert on andexanet alfa, used to reverse factor Xa inhibitors, after post-marketing data and the ANNEXA-I trial sho…
9 months, 1 week ago
HER2+ Lung Cancer at ESMO 2025
Episode 597
Drs. Yu and Herzberg discuss recent developments in HER2- and EGFR-targeted therapies for lung cancer, focusing on clinical trial results at ESMO 202…
9 months, 1 week ago
HER2+ Lung Cancer Breakthroughs: Sequencing Therapies and Next-Gen Innovations
Episode 596
Drs. Herzberg and Yu continue their discussion on emerging clinical data presented at ESMO and WCLC 2025. They highlight recent advancements in HER2-…
9 months, 1 week ago
HER2+ Lung Cancer Breakthroughs: New Targeted Therapies Explained
Episode 595
Drs. Herzberg and Yu explore emerging clinical data from the 2025 meetings of the European Society For Medical Oncology (ESMO) and World Conference o…
9 months, 2 weeks ago